Jean-Marie Bassett, born in the London area, is half-British/half-French, but now living in The Netherlands, (so fairly European), graduated in Chemistry at London University. He took his PhD at Bristol University in Organometallic Chemistry and completed his academic career in organometallics at the Technical University Munich with a Royal Society European Fellowship, followed by the City University London, before joining Royal Dutch Shell Research in Amsterdam. Combining the qualities of a scientific education and business instincts, Jean-Marie embarked on a career in business development and product management for Fine Chemicals and Specialities at Shell, Boehringer Mannheim, FRP Services and Helm before finally joining TNO in Delft. At TNO, the Dutch Applied Research organisation, he has been active in setting up the business in innovative technologies for chemicals processing. Jean-Marie has published about 20 articles in organometallics and later in technology development. For relaxation Jean-Marie plays golf, reads medieval history and plays the piano when nobody is around!

Teknoscienze - Viale Brianza 22, Milano - ITALY - P.IVA 06817720151      -

Teknoscienze S.r.l. © 2012 - tutti i diritti riservati -

Sito realizzato da Luis A. Alburqueque Diaz

Jean-Marie Bassett

C. Oliver Kappe

Professor C. Oliver Kappe received his diploma- (1989) and doctoral (1992) degrees in organic chemistry from the University of Graz where he worked with Professor Gert Kollenz on cycloaddition and rearrangement reactions of acylketenes. After periods of postdoctoral research work on reactive intermediates and matrix isolation spectroscopy with Curt Wentrup at the University of Queensland in Brisbane, Australia (1993-1994) and on synthetic methodology/alkaloid synthesis with Albert Padwa at Emory University in Atlanta, USA (1994-1996), he moved back to the University of Graz in 1996 to start his independent academic career. He obtained his “Habilitation” in 1998 in organic chemistry and was appointed Associate Professor in 1999. From 2011-2016 he held the position of Professor of “Technology of Organic Synthesis” (Organische Synthesetechnologie) at the University of Graz. He currently is Key Researcher at the Research Center Pharmaceutical Engineering (RCPE) in Graz.

The co-author of ca. 350 publications, his main research interest for the past 10 years focused on enabling and process intensification technologies in synthetic organic chemistry, in particular on the continuous generation of Active Pharmaceutical Ingredients (APIs). From 2010 he has been Editor-in-Chief of the Journal of Flow Chemistry and a Board Member of the Flow Chemistry Society.

Jesús Alcázar studied in Universidad de Castilla-La Mancha in Ciudad Real where he got his bachelor degree in 1990 and Ph. D. in 1996. As Ph. D. student he stayed for 6 months at the Royal Danish School of Pharmacy (Copenhagen, Denmark) under the direction of Prof. Michael Begtrup.  In 1995 he joined Janssen-Cilag at the research center in Toledo. Currently he is Senior Principal Scientist at Janssen Research and Development. In this position he is involved in the implementation of novel technologies in Drug Discovery in Toledo and in collaboration with other J&J sites worldwide. In this role he has led the successful implementation of 3 different technologies: microwave, H-CUBE and Flow chemistry. From this work he has been author of more than 45 articles, 4 reviews and 3 book chapters. In addition he has successfully applied these technologies to Medicinal Chemistry programs with 4 compounds selected as clinical candidates. This part of the work is reflected as inventor in more than 25 patent applications. He has also been invited speaker in more than 10 international symposiums.

Jesus Alcazar

I got the degree in “Chimica Industriale” at the University of Turin in 1986. I joined “3M Reseach Italy” in 1988, Ferrania site, working as researcher in the Organic Synthesis Laboratory about imaging chemicals. I worked in the Chemical Area up to March 2011, and I left the company as responsible of the Production, Research&Development and Sales of fine chemicals. I joined la Mesta in April 2011 and I am working in the Innovation and Commercial Area.

Massimo Bertoldi

Wim Dermaut obtained his Ph.D. in physical organic chemistry at the Structural Chemistry group of the University of Antwerp in 2002. He then joined Janssen Pharmaceutica (Johnson & Johnson) where he worked in the Process Safety Lab for 6 years and in the Preparative Chromatography Group for 3 years. In 2011 he joined Agfa as an R&D manager, focusing on process development and scale up, safety testing and technology scouting. Since 2014, he is the project manager of the “Atom” project, a funded research consortium between academia and industry, aiming at the development of a flow chemistry community in Flanders.



Wim Dermaut

Viktor Gyollai

He was born and graduated in Hungary, earned his Ph.D. at the University of Debrecen in the field of carbohydrate chemistry in 2001. Started his industrial career at TEVA Pharmaceuticals as a project leader at Synthetic R&D where he became the co-author of 8 patents on the synthesis and characterisation of generic drug molecules and their polymorphic forms till the end of 2006.

In 2007, he joined the research group of Prof. Licheng Sun at Royal Technical University in Stockholm to synthesise Mn- , Ru- and Iridium-based complexes as potential catalysts for the catalytical oxidation of water to oxygen.

He moved back to Hungary in 2009 and joined Thalesnano as a Senior Flow Chemist. Later he became the Head of Chemistry. He was involved in almost all chemical and instrument development projects, gave presentations on conferences and customers’ sites.

He was offered the position of Head of Continuous Technologies at Ubichem Pharma Group in 2012 to investigate a number of different types of flow processes.

In October 2014, he joined AM Technology to become the Head of Chemical Laboratories.

Gareth Jenkins

An experienced senior business manager with a proven track record of growing chemical sciences-based businesses. I have successfully expanded the services of business I work with by assessing core competencies and potential market opportunities, working with management teams to create winning business plans and leading marketing and selling activities to increase sales in existing and new markets, including the re-branding and re-positioning of the business. This experience has been gained working with businesses focused on drug discovery support, drug development support and small scale chemical manufacture, spanning laboratory, kilo-lab and pilot plant scales. I have held a number of key senior management positions covering marketing, sales, commercial, technical and quality roles

Anne Kaaden studied business chemistry at the Christian Albrechts Universität in Kiel and started her career in the area of continuous flow in 2012 for Ehrfeld Mikrotechnik BTS. As a global Key Account Manager and Head of Marketing her important fields of activity are lying in preparation of workshops, commissioning of equipment and organizing fairs and conferences. One favourite activity of Anne Kaaden is giving lectures and training sessions for this new technology platform of micro- and millireactors.

Anne Kaaden

I have earned a master’s degree in chemical engineering from Nagoya University, Japan, in 2008. After assigning to the current position at Technical Development Group, Kobe Steel, LTD., I worked for the development of the pressure swing adsorption system for carbon monoxide separation from combustion exhaust gas in iron making plants and petrochemical plants from 2008 to 2011. I am joining to the research and development for micro chemical process technologies from 2011 to present. My current tasks are to establish the methodology for device and process designs of multichannel large capacity micro channel reactor and to develop the applications of our device, stacked multi-channel reactor (SMCR®), for bulk chemical industries.

Akira Matsuoka

Dr. D. Tyler McQuade, Professor of Chemical and Life Science Engineering at Virginia Commonwealth University, has a background in flow chemistry and catalysis. Dr. McQuade published over 80 manuscripts (H-Factor = 33), patents and book chapters on topics ranging from catalysis to macromolecules to pharmaceutical agent synthesis. Dr. McQuade started the Medicines for All Initiative with his close colleague Professor Frank Gupton. This Bill & Melinda Gates Foundation funded initiative has reduced production costs of a variety of anti-viral compounds such as nevirapine. Dr. McQuade has had a wide range of professional experiences including program manager and later the deputy director of DARPA’s Defense Sciences Office (DSO), a visiting group leader at the Max Planck Institute of Colloids and Interfaces and a visiting professor in the Food and Nutrition Toxicology Department at the ETH-Zurich. Dr. McQuade received a PhD degree in Chemistry from the University of Wisconsin and a BS in Chemistry and BS in Biology from UC Irvine. He was a NIH Post-Doctoral Fellow at MIT prior to starting his independent research career.

Tyler McQuade

Roger-Marc Nicoud holds a PhD from University of Lorraine in process simulation for the nuclear industry. He joined Separex in 1987, first as a Technical Director and then as a Managing Director until 1995. Between 1993 and 1995, he also occupied a position of Professor and Head of a research laboratory involved in thermodynamics at the University of Lorraine. Roger-Marc Nicoud founded Novasep in 1995 with the vision to develop comprehensive solutions for the production of bio- and synthetic molecules. Novasep became a leader serving the life sciences industry with a recognized portfolio of innovative technologies. He held the position of CEO of Novasep until October 2012, and Chairman of the Novasep Supervisory Board until February 2014. Roger-Marc Nicoud founded Ypso-Facto in 2014 as a service company offering assistance to industrial firms to develop, optimize and secure their chemical and bioprocesses. He has published the book Chromatographic processes: modeling, simulation and design1 in 2015.


1Chromatographic Processes - Modeling, Simulation, and Design, Roger-Marc Nicoud, 672 pages, Cambridge University Press, Cambridge Series in Chemical Engineering, New-York (2015), ISBN: 9781107082366

Roger-Marc Nicoud

Peter Poechlauer received a PhD in organic chemistry from Innsbruck University in 1986.

2 years of post-doc studies at Munich University in the Laboratories of Prof. Rolf Huisgen  followed. Both activities were dedicated to the elucidation of organic reaction pathways.

In 1990 he joined Chemie Linz, later OMV, as a synthetic chemist.

Since 1996 he has worked with DSM as scientist, project leader and competence manager. Focal areas: biocatalysis and oxidation chemistry.

2003 – 2007 he headed a department of process technology.

Since 2007 he has worked as principal scientist with a focus on process intensification and micro reactor technology.

Since 2014 with the formation of DPx/Patheon he has been responsible for Innovation Management.

Peter Poechlauer

Marc-Olivier Simon studied molecular physicochemistry and organic chemistry at the University of Paris Sud (Paris 11, France). He holds a PhD in chemistry from Pierre & Marie Curie University (Paris 6, France). He completed his academic experience at McGill University in Montreal (Canada). During this period, he co-authored 12 papers and 1 book chapter in the fields of organometallic catalysis and organic synthesis. He joined SRT Expertise & Conseil in 2012 where he gained further skills and expertise in synthetic approaches, production processes, applications and markets of organic molecules but also in business and strategy in diversified industries including pharmaceuticals, cosmetics, agrochemicals, green biotechs and materials.

He joined Ypso-Facto at its creation in 2014 and was appointed Chemistry Business Unit Manager in 2017.

Marc-Oliver Simon

Flavien Susanne graduated in 2001 with a Master degree in Engineering and in 2003 from a Chemical Engineering degree from the University of Normandy, France.

In 2004, Flavien joined Pfizer UK, working in the R&D department. In 2006, he joined the new continuous process development team, leading the development of the first Pfizer end to end flow process.

In 2011, Flavien joined Novartis Switzerland, working in the Continuous Manufacturing Unit, leading the development of flow process development and the implementation in GMP facilities.

In 2014, Flavien joined GSK leading the continuous process engineering team.

Flavien has been really active with the academia in all these years working closely with CMAC and MIT for the development of new methodology and technology for flow processing.

Flavien Suzanne

John Tsanaktsidis

Dr Tsanaktsidis is a Research Director at CSIRO Manufacturing. He applies his extensive background and experience in scientific research, management, business development, technology commercialisation, and business leadership to deliver commercial value through the creation and translation of innovative technical solutions to the chemical manufacturing industry.

He is a Fellow of the RACI and Chair of the Organic Chemistry Division of the RACI, the peak body for chemists in Australia.

Dr Tsanaktsidis is an experienced synthetic organic chemist focused on the development and translation of chemistry solutions to the chemical industry. He has the ability to build rapport with colleagues, collaborators, and customers, and has demonstrated an ability to deliver on complex industrial and multidisciplinary projects. In recent years Dr Tsanaktsidis has led the establishment Australia’s first continuous flow processing (flow chemistry) laboratory at CSIRO Manufacturing, for the sustainable and efficient production of commercially important fine chemicals, polymers, and pharmaceuticals. This cutting edge laboratory represents radical paradigm shift in the field of chemical manufacturing.

Dr Tsanaktsidis has authored or co-authored over 60 peer reviewed papers, patents, and book chapters, and has an h-index of 15. His efforts have been recognised by CSIRO for Business Excellence (2003) and Project Management (2004), and through a Chief's Innovation Award for his efforts in continuous flow chemistry (2012), and by The Flinders University of South Australia in 2006 through a Distinguished Alumni Award.

Charlotte Wiles

Chief Executive Officer, Chemtrix BV, Chemelot Campus, Gate 2, Urmonderbaan 22, 6167 RD, Geleen, The Netherlands, c.wiles@chemtrix.com


Starting her research in the area of continuous flow synthesis in 2000, Charlotte obtained her PhD in 2003 entitled ‘Microreactors in Organic Synthesis’ from the University of Hull (UK). This was followed by 5 years of Post-Doctoral research into the rapidly developing field of continuous flow synthesis, specifically in the area of small molecule synthesis.

In 2008, Charlotte joined Chemtrix BV (a spin out of the University of Hull) as a Senior Chemist where she worked on the commercialisation of lab-scale micro reactor apparatus, followed by the development of scale up strategies to access kilo-scale production. In 2010 she was promoted to Chief Technology Officer within Chemtrix BV and in August 2013 to CEO, where she continues to research and develop continuous flow systems and solutions for both industrial and academic partners. More recent developments have focused on the development of advanced industrial flow reactors, suited towards the development of flexible tonne-scale production plants, performed in cooperation with 3M Germany.